Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

Geert C. van Almen, Melissa Swinnen, Paolo Carai, Wouter Verhesen, Jack P. M. Cleutjens, Jan D'hooge, Fons K. Verheyen, Yigal M. Pinto, Blanche Schroen, Peter Carmeliet, Stephane Heymans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)318-328
JournalJournal of Molecular and Cellular Cardiology
Issue number3
Publication statusPublished - Sep 2011


  • Akt
  • Cardiomyopathy
  • Doxorubicin
  • Extracellular matrix
  • Thrombospondin-2

Cite this